A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 1000 participants.
Also called NCT06713239
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 1,000 participants
- Sponsor
- Cleerly, Inc.
- Registry
-
NCT06713239
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT06713239. Randomized; no masking; primary purpose diagnostic. Start 2024-12-18 (actual); primary completion 2026-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
- Acronym
- PARAMOUNT
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Cleerly Labs and Cleerly ISCHEMIA
- Lead sponsor
- Cleerly, Inc.
Record details
- Record id
cardio:ct-nct06713239- Content hash
5c9edef1175f35a786bb09621170bce264522e10a77eba58536efb95a6c40ba3